Beta-endorphin infusion alters pancreatic hormone and glucose levels during exercise in rats

ß-Endorphin (BE) infusion at rest can influence insulin and glucagon levels and thus may affect glucose availability during exercise. To clarify the effect of BE on levels of insulin, glucagon and glucose during exercise, 72 untrained male Sprague-Dawley rats were infused i.v. with either: (1) BE (bolus 0.05?mg?·?kg ^-1 +0.05?mg?·?kg ^-1?·?h ^-1, n?=?24); (2) naloxone (N, bolus 0.8?mg?·?kg ^-1?+?0.4?mg?·?kg ^-1, n?=?24); or (3) volume-matched saline (S, n?=?24). Six rats from each group were killed after 0, 60, 90 or 120 min of running at 22?m?·?min ^-1, at 0% gradient. BE infusion resulted in higher plasma glucose levels at 60?min [5.93 (0.32)?mM] and 90?min [4.16 (0.29)?mM] of exercise compared to S [4.62 (0.27) and 3.41 (0.26?mM] and N [4.97 (0.38) and 3.44 (0.25)?mM]. Insulin levels decreased to a greater extent with BE [21.5 (0.9) and 18.3 (0.6) uIU?·?ml ^-1] at 60 and 90?min compared to S [24.5 (0.5) and 20.6 (0.6)?uIU?·?ml ^-1] and N [24.5 (0.4) and 21.6 (0.7)?uIU?· ml ^-1] groups. Plasma C-peptide declined to a greater extent at 60 and 90?min of exercise with BE infusion compared to both S and N. BE infusion increased glucagon at all times during exercise compared to S and N. These data suggest that BE infusion during exercise influences plasma glucose by augmenting glucagon levels and attenuating insulin release.